SPIE SA (SPIE.PA)

FR0012757854 - Common Stock

29.68  +0.46 (+1.57%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to SPIE. SPIE was compared to 44 industry peers in the Commercial Services & Supplies industry. SPIE has a medium profitability rating, but doesn't score so well on its financial health evaluation. SPIE has a correct valuation and a medium growth rate.



6

1. Profitability

1.1 Basic Checks

In the past year SPIE was profitable.
SPIE had a positive operating cash flow in the past year.
SPIE had positive earnings in each of the past 5 years.
In the past 5 years SPIE always reported a positive cash flow from operatings.

1.2 Ratios

SPIE's Return On Assets of 2.31% is in line compared to the rest of the industry. SPIE outperforms 53.66% of its industry peers.
SPIE has a Return On Equity (11.64%) which is comparable to the rest of the industry.
The Return On Invested Capital of SPIE (6.02%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for SPIE is below the industry average of 7.74%.
The 3 year average ROIC (5.25%) for SPIE is below the current ROIC(6.02%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.31%
ROE 11.64%
ROIC 6.02%
ROA(3y)2.09%
ROA(5y)1.75%
ROE(3y)10.11%
ROE(5y)8.83%
ROIC(3y)5.25%
ROIC(5y)4.73%

1.3 Margins

SPIE has a Profit Margin (2.40%) which is comparable to the rest of the industry.
SPIE's Profit Margin has improved in the last couple of years.
SPIE has a Operating Margin (5.24%) which is comparable to the rest of the industry.
SPIE's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 40.38%, SPIE perfoms like the industry average, outperforming 46.34% of the companies in the same industry.
SPIE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.24%
PM (TTM) 2.4%
GM 40.38%
OM growth 3Y13.03%
OM growth 5Y5.09%
PM growth 3Y50.68%
PM growth 5Y14.88%
GM growth 3Y-1.1%
GM growth 5Y1.3%

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SPIE is destroying value.
SPIE has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SPIE has more shares outstanding
Compared to 1 year ago, SPIE has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 1.46, we must say that SPIE is in the distress zone and has some risk of bankruptcy.
SPIE's Altman-Z score of 1.46 is on the low side compared to the rest of the industry. SPIE is outperformed by 60.98% of its industry peers.
SPIE has a debt to FCF ratio of 3.78. This is a good value and a sign of high solvency as SPIE would need 3.78 years to pay back of all of its debts.
SPIE has a Debt to FCF ratio of 3.78. This is in the better half of the industry: SPIE outperforms 70.73% of its industry peers.
A Debt/Equity ratio of 1.10 is on the high side and indicates that SPIE has dependencies on debt financing.
The Debt to Equity ratio of SPIE (1.10) is worse than 63.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 3.78
Altman-Z 1.46
ROIC/WACC0.98
WACC6.15%

2.3 Liquidity

SPIE has a Current Ratio of 0.79. This is a bad value and indicates that SPIE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of SPIE (0.79) is worse than 85.37% of its industry peers.
SPIE has a Quick Ratio of 0.79. This is a bad value and indicates that SPIE is not financially healthy enough and could expect problems in meeting its short term obligations.
SPIE's Quick ratio of 0.77 is on the low side compared to the rest of the industry. SPIE is outperformed by 78.05% of its industry peers.
Industry RankSector Rank
Current Ratio 0.79
Quick Ratio 0.77

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 45.01% over the past year.
SPIE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 19.93% yearly.
Looking at the last year, SPIE shows a quite strong growth in Revenue. The Revenue has grown by 9.23% in the last year.
SPIE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.44% yearly.
EPS 1Y (TTM)45.01%
EPS 3Y61.76%
EPS 5Y19.93%
EPS Q2Q%-21.84%
Revenue 1Y (TTM)9.23%
Revenue growth 3Y9.43%
Revenue growth 5Y5.44%
Sales Q2Q%118.03%

3.2 Future

Based on estimates for the next years, SPIE will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.56% on average per year.
Based on estimates for the next years, SPIE will show a small growth in Revenue. The Revenue will grow by 5.18% on average per year.
EPS Next Y23.32%
EPS Next 2Y17.1%
EPS Next 3Y13.56%
EPS Next 5YN/A
Revenue Next Year14.22%
Revenue Next 2Y10.28%
Revenue Next 3Y8.45%
Revenue Next 5Y5.18%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 22.32 indicates a rather expensive valuation of SPIE.
SPIE's Price/Earnings ratio is in line with the industry average.
SPIE is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.73, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 10.21, the valuation of SPIE can be described as reasonable.
Based on the Price/Forward Earnings ratio, SPIE is valued a bit cheaper than 73.17% of the companies in the same industry.
SPIE's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.83.
Industry RankSector Rank
PE 22.32
Fwd PE 10.21

4.2 Price Multiples

SPIE's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, SPIE is valued a bit cheaper than the industry average as 70.73% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.59
EV/EBITDA 8.69

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of SPIE may justify a higher PE ratio.
A more expensive valuation may be justified as SPIE's earnings are expected to grow with 13.56% in the coming years.
PEG (NY)0.96
PEG (5Y)1.12
EPS Next 2Y17.1%
EPS Next 3Y13.56%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.86%, SPIE has a reasonable but not impressive dividend return.
The stock price of SPIE dropped by -20.30% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
SPIE's Dividend Yield is a higher than the industry average which is at 3.89.
SPIE's Dividend Yield is a higher than the S&P500 average which is at 2.24.
Industry RankSector Rank
Dividend Yield 2.86%

5.2 History

The dividend of SPIE is nicely growing with an annual growth rate of 6.15%!
Dividend Growth(5Y)6.15%
Div Incr Years4
Div Non Decr Years4

5.3 Sustainability

SPIE pays out 62.14% of its income as dividend. This is not a sustainable payout ratio.
SPIE's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP62.14%
EPS Next 2Y17.1%
EPS Next 3Y13.56%

SPIE SA

EPA:SPIE (12/20/2024, 7:00:00 PM)

29.68

+0.46 (+1.57%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)10-31 2024-10-31
Earnings (Next)N/A N/A
Inst Owners48.33%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.95B
Analysts84.44
Price Target41.77 (40.73%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.86%
Dividend Growth(5Y)6.15%
DP62.14%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.56%
PT rev (3m)1.81%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)1.06%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.04%
Valuation
Industry RankSector Rank
PE 22.32
Fwd PE 10.21
P/S 0.54
P/FCF 6.59
P/OCF 5.94
P/B 2.6
P/tB N/A
EV/EBITDA 8.69
EPS(TTM)1.33
EY4.48%
EPS(NY)2.91
Fwd EY9.79%
FCF(TTM)4.5
FCFY15.17%
OCF(TTM)5
OCFY16.84%
SpS55.43
BVpS11.43
TBVpS-17.86
PEG (NY)0.96
PEG (5Y)1.12
Profitability
Industry RankSector Rank
ROA 2.31%
ROE 11.64%
ROCE 9.36%
ROIC 6.02%
ROICexc 6.58%
ROICexgc N/A
OM 5.24%
PM (TTM) 2.4%
GM 40.38%
FCFM 8.12%
ROA(3y)2.09%
ROA(5y)1.75%
ROE(3y)10.11%
ROE(5y)8.83%
ROIC(3y)5.25%
ROIC(5y)4.73%
ROICexc(3y)6.94%
ROICexc(5y)6.16%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.13%
ROCE(5y)7.29%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y20.79%
ROICexc growth 5Y9.6%
OM growth 3Y13.03%
OM growth 5Y5.09%
PM growth 3Y50.68%
PM growth 5Y14.88%
GM growth 3Y-1.1%
GM growth 5Y1.3%
F-Score4
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF 3.78
Debt/EBITDA 2.55
Cap/Depr 24.39%
Cap/Sales 0.89%
Interest Coverage 250
Cash Conversion 101.22%
Profit Quality 338.43%
Current Ratio 0.79
Quick Ratio 0.77
Altman-Z 1.46
F-Score4
WACC6.15%
ROIC/WACC0.98
Cap/Depr(3y)24.6%
Cap/Depr(5y)27.92%
Cap/Sales(3y)0.82%
Cap/Sales(5y)0.89%
Profit Quality(3y)292.1%
Profit Quality(5y)409.24%
High Growth Momentum
Growth
EPS 1Y (TTM)45.01%
EPS 3Y61.76%
EPS 5Y19.93%
EPS Q2Q%-21.84%
EPS Next Y23.32%
EPS Next 2Y17.1%
EPS Next 3Y13.56%
EPS Next 5YN/A
Revenue 1Y (TTM)9.23%
Revenue growth 3Y9.43%
Revenue growth 5Y5.44%
Sales Q2Q%118.03%
Revenue Next Year14.22%
Revenue Next 2Y10.28%
Revenue Next 3Y8.45%
Revenue Next 5Y5.18%
EBIT growth 1Y8.59%
EBIT growth 3Y23.69%
EBIT growth 5Y10.81%
EBIT Next Year74.3%
EBIT Next 3Y26.2%
EBIT Next 5YN/A
FCF growth 1Y53.45%
FCF growth 3Y9.64%
FCF growth 5Y15.83%
OCF growth 1Y48.52%
OCF growth 3Y8.39%
OCF growth 5Y14.3%